Negara: Armenia
Bahasa: Inggris
Sumber: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
cynara scolymus extract
Laboratoires Rosa-Phytopharma
առկա չէ (A05AX)
cynara scolymus extract
200mg
tablets coated
(60/2x30/) in blister, (180/6x30/) in blister
OTC
Registered
2019-12-12
SmPC CHOPHYTOL, coated tablet SUMMARY OF PRODUCT CHARACTERISTICS 1) NAME OF THE MEDICINAL PRODUCT CHOPHYTOL® 2) QUALITATIVE AND QUANTITATIVE COMPOSITION Artichoke (dry aqueous extract of leaves) on maltodextrin 200.000 mg For a coated tablet. Excipient with known effect: each tablet contains sucrose (0.08 g), methyl parahydroxybenzoate (E218), ethyl parahydroxybenzoate (E214). For a full list of excipients, see section 6.1. 3) PHARMACEUTICAL FORM Coated tablet. _DESCRIPTION _ Round biconvex tablets with brown coating. 4) CLINICAL PARTICULARS _4.1. THERAPEUTIC INDICATIONS _ Traditionally indicated to improve the renal and digestive elimination functions: - digestion recovery - improvement in kidneys excretory function _4.2. POSOLOGY AND METHOD OF ADMINISTRATION _ Oral use. For adults only. 1–2 tablets three times a day with water before the meal or when symptoms occur. Treatment course duration is 2–3 weeks. _4.3. CONTRAINDICATIONS _ - hypersensitivity to the active substance or to any of the excipients listed in section 6.1. - cholelithiasis - severe hepatic failure - acute diseases of liver, kidneys, bile duct and urinary tract - patients with hereditary fructose intolerance, glucose-galactose malabsorption or sucrose- isomaltase deficiency - children under age of 18 - pregnancy and lactation _4.4. SPECIAL WARNINGS AND PRECAUTIONS FOR USE _ Do not administer in case of bile tract obstruction and severe hepato-cellular insufficiency. In case of diarrhea or abdominal pains, the treatment must be stopped. SmPC CHOPHYTOL, coated tablet This medicinal product contains sucrose. Patient with problems of fructose intolerance, glucose- galactose malabsorption syndrome or sucrase-isomaltase insufficiency should not take this medicine. This medicine contains parahydroxybenozate and may cause allergic reactions (possibly delayed). _4.5. INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION _ No data present with regard to interaction with other medicinal products and other forms of interaction. _4.6. Baca dokumen lengkapnya